Latest Share Chat

REMOVE ADS

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

1,962.50 0.00 (0.00%)

Bid:

1,910.00

Ask:

1,999.00

Spread: 89.00 (4.66%)

Market Cap: £78.67b

Last checked at -

Intraday Glaxosmithkline Share Chart

REMOVE ADS

Glaxosmithkline News

GSK's Nucala backed in China for chronic obstructive pulmonary disease

(Alliance News) - GSK PLC on Monday said mepolizumab, sold under the brand name Nucala, has been approved in China for use in adults with chronic obst...

LONDON BRIEFING: Auction Technology rejects 11 FitzWalter buyout bids

(Alliance News) - Balfour Beatty sells ten UK assets for GBP87 million, Wizz Air and Ryanair report growth in passenger numbers for December, while Au...

GSK's COPD treatment approved by Chinese regulators

(Sharecast News) - Pharma giant GSK has received regulatory approval in China for its Nucala treatment for adults with inadequately controlled chronic...

UK dividends calendar - next 7 days

London's FTSE 100 closes lower in shortened Christmas Eve session

FTSE 100 down 0.2%; FTSE 250 ⁠down ‌0.07% *

LONDON MARKET CLOSE: FTSE fails to sparkle in tame pre-holiday trade

(Alliance News) - The FTSE 100 drifted lower on Wednesday in lacklustre trading ahead of the Christmas break, although a chunky disposal by BP brought...

LONDON MARKET OPEN: FTSE mixed in shortened Christmas Eve trade

(Alliance News) - Stock prices in London opened modestly lower on Wednesday, during a shortened trading session ahead of the Christmas holiday break.

Samsung Biologics to buy its first US drug production facility from GSK for $280 million

SEOUL, ⁠Dec ‌22 (Reuters) - South Korea's ⁠Samsung Biologics said on Monday it is ‍acquiring its first U.S. drug production ‍facility from GSK for $...